Ankit Desai, MD
Retina Specialist · Plainfield, ILNPI 1346553450
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by AbbVie at 38.3% of the total. Reporting peaked in 2021 at $2,099 and has fallen 73.5% since, to $557 in 2025.
Across 89 payments — averaging $65.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alimera Sciences, Inc.$2K
- Apellis Pharmaceuticals, Inc.$552
- Biotissue Holdings Inc.$254
- Coopervision Inc.$167
- Regeneron Healthcare Solutions, Inc.$136
- plus $847 from 12 others
What the payments were for
- Consulting fees$2,02935%
- Speaking & faculty fees$1,36724%
- Food & beverage$2,37941%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $2,221 |
| Alimera Sciences, Inc. | 13 | $1,618 |
| Apellis Pharmaceuticals, Inc. | 16 | $552 |
| Biotissue Holdings Inc. | 12 | $254 |
| Coopervision Inc. | 1 | $167 |
| Regeneron Healthcare Solutions, Inc. | 4 | $136 |
| Topcon Healthcare, Inc. | 3 | $132 |
| Genentech USA, Inc. | 5 | $124 |
| Novartis | 2 | $122 |
| Biogen | 5 | $115 |
| Coherus Oncology, Inc. | 4 | $106 |
| Astellas Pharma US Inc | 4 | $96 |
| ANI Pharmaceuticals, Inc. | 1 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Eyepoint US, Inc. | 1 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $22 |
| Ocular Therapeutix, Inc. | 1 | $19 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OZURDEX$2,029
- Iluvien$1,200
- Clariti Contact Lens$167
- BEOVU$120
How this compares
$5,795 in reported general payments places this provider in the 65th percentile of 70 retina specialist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 105 | $4,051 |
| Latanoprost | 77 | $1,169 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $879 |
| Ofloxacin | 74 | $723 |
| Brimonidine Tartrate | 26 | $326 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $317 |
| Timolol Maleate | 19 | $269 |
| Prednisone | 20 | $28 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Plainfield
- Mathew MaccumberHarvey$219K
- Rahul KomatiChicago$143K
- Kourous RezaeiHarvey$126K
- Kirk PackoHarvey$86K
- David OrthHarvey$70K
- Veena RaijiChicago$69K
- John PollackJoliet$68K
- Timothy FloodHarvey$57K
- Brian LarsenLombard$38K
- Serge DebustrosHarvey$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.